Back
United States Cellular Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
74
USM
United States Cellular
Last Price:
61.31
Seasonality Move:
3.11%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
16.64
Seasonality Move:
5.98%
Buy
74
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $59.49. The Score for USM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $16.59. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $59.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $16.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.23 | Buy |
| Relative Strength Index (14 RSI): | 57.33 | Buy |
| Chaikin Money Flow: | 111271 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.69 - 58.87) | Buy |
| Bollinger Bands (100): | (52.85 - 57.49) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.73 | Sell |
| Relative Strength Index (14 RSI): | 25.39 | Sell |
| Chaikin Money Flow: | -372051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.08 - 30.28) | Sell |
| Bollinger Bands (100): | (30.09 - 59.75) | Sell |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.11 | Buy |
| 20-day SMA: | 57.08 | Buy |
| 50-day SMA: | 55.75 | Buy |
| 200-day SMA: | 47.06 | Buy |
| 8-day EMA: | 59.09 | Buy |
| 20-day EMA: | 57.66 | Buy |
| 50-day EMA: | 56.03 | Buy |
| 200-day EMA: | 48.77 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.21 | Sell |
| 20-day SMA: | 19.2 | Sell |
| 50-day SMA: | 38.58 | Sell |
| 200-day SMA: | 38.52 | Sell |
| 8-day EMA: | 18.06 | Sell |
| 20-day EMA: | 22.12 | Sell |
| 50-day EMA: | 32.71 | Sell |
| 200-day EMA: | 35.61 | Sell |
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.18 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
United States Cellular Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||